| Literature DB >> 22877499 |
Hilary J Thomson1, Sian Thomas.
Abstract
BACKGROUND: Researchers and publishers have called for improved reporting of external validity items and for testing of existing tools designed to assess reporting of items relevant to external validity. Few tools are available and most of this work has been done within the field of health promotion.Entities:
Mesh:
Year: 2012 PMID: 22877499 PMCID: PMC3481477 DOI: 10.1186/1471-2458-12-633
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Reworded external validity items and extent of reporting by item (n = 39 studies) *
| 1 | Are data presented on variations in participation rate in improved housing interventions by a) setting b) delivery staff/organisations c) residents (for intervention among general target population not study area) | 0 | 0 | 0 | 39 |
| 2 | Is the intended target audience for adoption clearly described | 11 | 18 | 8 | 2 |
| 3 | Is the intended target setting for adoption clearly described? | 4 | 27 | 5 | 3 |
| 4 | Is there analysis of the baseline socio-demographic and ‘condition tested’ (health status) of evaluation participants versus non-participants? (relating to evaluation population only) | 0 | 0 | 2 | 37 |
| 5 | Are data presented on consistency of implementation of intervention & its different components? | 0 | 2 | 2 | 35 |
| 6 | Are data presented on the level of training of experience required to deliver the programme or quality of implementation by different types of staff? | 0 | 1 | 1 | 37 |
| 7 | Is information reported on whether/how the intervention is modified to individuals/households within the study? | 5 | 6 | 0 | 11 |
| 8 | Are data presented on mediating factors or processes (mechanisms) through which the intervention had an impact? | 2 | 12 | 4 | 21 |
| 9 | Are the reported health (even if only one measure of health is comparable) outcomes comparable to wider policy/other studies? | 23 | 14 | 0 | 2 |
| 10 | Have additional outcomes of potential adverse impacts been reported? e.g. socio-economic impacts | 4 | 21 | 1 | 13 |
| 11 | Have authors demonstrated consideration of variation in reported health outcomes (key outcome of interest) by population sub-groups, or intervention setting/delivery staff? | 2 | 4 | 1 | 32 |
| 12 | Is there sensitivity analysis of dose–response/threshold level required to observe health effect (effect on key outcome of interest not proxies)? | 3 | 4 | 1 | 31 |
| 13 | Are data on costs presented? Are standard economic/accounting methods used? | 2 | 19 | 0 | 18 |
| 14 | Are long term effects reported? (12 months or longer since exposure to the intervention) | 10 | 13 | 4 | 11 |
| 15 | Are data reported on the sustainability (or reinvention or evolution) of programme implementation and intervention, at least 12 months after the formal evaluation? | 0 | 0 | 0 | 29 |
| 16 a | Is the drop-out rate/attrition reported? | 19 (Yes) | 10 (N/A) | ||
| 16 b | Are data on attrition by baseline health status of dropouts reported and are analyses conducted of the representativeness of remaining sample at time of final follow-up (or main follow-up time point- as appropriate)? | 0 | 0 | 0 | 29 (10 N/A) |
(adapted from Green LW, Glasgow RE. Evaluating the Relevance, Generalization, and Applicability of Research: Issues in External Validation and Translation Methodology. Eval Health Prof 2006;29(1):126–153.)
* see Additional file 1 for full details of external validity assessment tool.
Number of external validity items reported in each study by domain
| Heyman et al. 2010 | RCT | A | 1 | 2 | 3 | 2 | 8 |
| Braubach et al. 2008 | CBA | A | 2 | 1 | 1 | 1 | 5 |
| Howden-Chapman et al. 2008 | RCT | A | 2 | 1 | 1 | 1 | 5 |
| Barton et al. 2007 | RCT | A | 2 | 1 | 3 | 2 | 8 |
| Howden-Chapman et al. 2007 | RCT | A | 2 | 0 | 3 | 1 | 6 |
| Platt et al. 2007 | CBA | A | 1 | 1 | 4 | 2 | 8 |
| Lloyd et al. 2008 | CBA | B | 1 | 0 | 3 | 2 | 6 |
| Shortt et al. 2007 | CBA | B | 2 | 2 | 2 | 2 | 8 |
| Somerville et al. 2000 | UBA | B | 2 | 1 | 3 | 1 | 7 |
| Hopton et al. 1996 | CBA | B | 2 | 0 | 2 | 1 | 5 |
| Warm Front Study Group 2006 | RC | C | 1 | 1 | 5 | 0 | 7 |
| Allen 2005 a | UBA | C | 1 | 1 | 2 | 2 | 6 |
| Allen 2005 b | UBA | C | 1 | 2 | 1 | 1 | 5 |
| Health Action Kirklees 2005 | R | C | 1 | 0 | 1 | 0 | 2 |
| Eick et al. 2004 | RCT | C | 2 | 1 | 4 | 2 | 9 |
| Winder et al. 2003 | UBA | C | 1 | 0 | 0 | 1 | 2 |
| Caldwell et al. 2001 | CBA | C | 2 | 2 | 3 | 2 | 9 |
| Green et al. 1999 | RC | C | 1 | 0 | 3 | 0 | 4 |
| Iversen et al. 1986 | CBA | C | 1 | 0 | 1 | 1 | 3 |
| | | 1.47 (1–2) | 0.84 (0–2) | 2.37 (0–4) | 1.26 (0–2) | 5.95 (2–9) | |
| Kearns et al. 2008 | CBA | A | 1 | 1 | 3 | 2 | 7 |
| Thomson et al. 2007 | CBA | A | 2 | 0 | 2 | 2 | 6 |
| Critchley et al. 2004 | CBA | A | 0 | 1 | 4 | 1 | 6 |
| Thomas et al. 2005 | CBA | B | 2 | 1 | 3 | 1 | 7 |
| Barnes et al. 2003 | CBA | B | 2 | 0 | 2 | 2 | 6 |
| Evans et al. 2002 | CBA | B | 1 | 0 | 2 | 0 | 3 |
| Blackman et al. 2001 | UBA | C | 2 | 0 | 2 | 2 | 6 |
| Wells 2000 | UBA | C | 2 | 0 | 1 | 2 | 5 |
| Ambrose 1999 | UBA | C | 2 | 1 | 3 | 2 | 8 |
| Halpern 1995 | XUBA | C | 2 | 1 | 2 | 1 | 6 |
| | | 1.6 (0–2) | 0.50 (0–1) | 2.40 (1–4) | 1.50 (0–2) | 6 (3–8) | |
| Cattaneo et al. 2006 | RC | B | 2 | 1 | 4 | 1 | 8 |
| Choudhary et al. 2002 | RC | B | 1 | 1 | 3 | 1 | 6 |
| Aga Khan Health Service 2001 | XCBA | B | 1 | 1 | 2 | 1 | 5 |
| Spiegel et al. 2003 | XCBA | C | 2 | 0 | 1 | 1 | 4 |
| Aiga et al. 2002 | XCBA | C | 1 | 1 | 3 | 0 | 5 |
| Wolff et al. 2001 | XCBA | C | 2 | 0 | 2 | 1 | 5 |
| | | 1.50 (1–2) | 0.67 (0–1) | 2.67 (1–4) | 0.83 (0–1) | 5.5 (4–8) | |
| Wilner et al. 1960 | CBA | A | 2 | 1 | 3 | 2 | 8 |
| McGonigle et al. 1936 | XCBA | B | 2 | 1 | 4 | 1 | 8 |
| Ferguson 1954 | RC | C | 1 | 0 | 1 | 1 | 3 |
| Chapin 1938 | UBA | C | 2 | 1 | 4 | 2 | 9 |
| | | 1.75 (1–2) | 0.75 (0–1) | 3.00 (2–4) | 1.50 (1–2) | 7.00 (3–9) | |
| 1.54 (0–2) | 0.72 (0–2) | 2.49 (0–4) | 1.28 (0–2) | 6.00 (2–9) | |||
Study design: RCT: Randomised Controlled Trial; CBA: Controlled Before & After; UBA: Uncontrolled Before & After; XCBA: Cross-sectional Controlled Before & After; XUBA: Cross-sectional Uncontrolled Before & After; RC: Retrospective controlled; R: Retrospective uncontrolled.
List of references available in reference 4 or from the author.